A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors.

by Rajkumar Venkatramani, Marcio Malogolowkin, Tom B Davidson, William May, Richard Sposto, Leo Mascarenhas
Published 2013-01-01

mRNA and miRNA Profiles of Exosomes from Cultured Tumor Cells Reveal Biomarkers Specific for HPV16-Positive and HPV16-Negative Head and Neck Cancer

by Sonja Ludwig, Priyanka Sharma, Petra Wise, Richard Sposto, Deborah Hollingshead, Janette Lamb, Stephan Lang, Muller Fabbri, Theresa L. Whiteside
Published 2020-11-01

Surveillance for radiation‐related late effects in childhood cancer survivors: The impact of using volumetric dosimetry

by Sally Cohen‐Cutler, Arthur Olch, Kenneth Wong, Jemily Malvar, Richard Sposto, Pierre Kobierski, Amit Sura, Louis S. Constine, David R. Freyer
Published 2021-02-01

Plasminogen Activator Inhibitor-1 Promotes the Recruitment and Polarization of Macrophages in Cancer

by Marta Helena Kubala, Vasu Punj, Veronica Rae Placencio-Hickok, Hua Fang, G. Esteban Fernandez, Richard Sposto, Yves Albert DeClerck
Published 2018-11-01

Biophysical markers of the peripheral vasoconstriction response to pain in sickle cell disease.

by Patjanaporn Chalacheva, Maha Khaleel, John Sunwoo, Payal Shah, Jon A Detterich, Roberta M Kato, Wanwara Thuptimdang, Herbert J Meiselman, Richard Sposto, Jennie Tsao, John C Wood, Lonnie Zeltzer, Thomas D Coates, Michael C K Khoo
Published 2017-01-01